Home » Reports » Broker Ratings » GlaxoSmithKline plc 7.8% Potential Upside Indicated by Liberum Capital

GlaxoSmithKline plc 7.8% Potential Upside Indicated by Liberum Capital

GlaxoSmithKline plc using EPIC/TICKER code (LON:GSK) had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘HOLD’ this morning by analysts at Liberum Capital. GlaxoSmithKline plc are listed in the Health Care sector within UK Main Market. Liberum Capital have set their target price at 1890 GBX on its stock. This is indicating the analyst believes there is a potential upside of 7.8% from today’s opening price of 1753 GBX. Over the last 30 and 90 trading days the company share price has increased 37.6 points and increased 94.4 points respectively. The 52 week high for the stock is 1796.4 GBX while the year low share price is currently 1408.8 GBX.

GlaxoSmithKline plc has a 50 day moving average of 1,709.00 GBX and a 200 day moving average of 1,619.45. There are currently 4,988,916,711 shares in issue with the average daily volume traded being 9,634,547. Market capitalisation for LON:GSK is £87,884,755,562 GBP.